These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 7901248)

  • 1. Treatment of chronic severe alopecia areata with topical diphenylcyclopropenone and 5% minoxidil: a clinical and immunopathologic evaluation.
    Shapiro J; Tan J; Ho V; Abbott F; Tron V
    J Am Acad Dermatol; 1993 Nov; 29(5 Pt 1):729-35. PubMed ID: 7901248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of severe alopecia areata with topical diphenylcyclopropenone and 5% minoxidil: a clinical and immunopathologic evaluation.
    Shapiro J; Tan J; Ho V; Tron V
    J Invest Dermatol; 1995 May; 104(5 Suppl):36S. PubMed ID: 7738390
    [No Abstract]   [Full Text] [Related]  

  • 3. Efficacy and safety of diphenylcyclopropenone alone or in combination with anthralin in the treatment of chronic extensive alopecia areata: a retrospective case series.
    Durdu M; Özcan D; Baba M; Seçkin D
    J Am Acad Dermatol; 2015 Apr; 72(4):640-50. PubMed ID: 25653027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical minoxidil in alopecia areata: no effect on the perifollicular lymphoid infiltration.
    Khoury EL; Price VH; Abdel-Salam MM; Stern M; Greenspan JS
    J Invest Dermatol; 1992 Jul; 99(1):40-7. PubMed ID: 1607678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical immunotherapy of severe alopecia areata with diphenylcyclopropenone (DPCP): experience in an Iranian population.
    Aghaei S
    BMC Dermatol; 2005 May; 5():6. PubMed ID: 15918897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical minoxidil (3%) in extensive alopecia areata, including long-term efficacy.
    Price VH
    J Am Acad Dermatol; 1987 Mar; 16(3 Pt 2):737-44. PubMed ID: 3549810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic steroids with or without 2% topical minoxidil in the treatment of alopecia areata.
    Olsen EA; Carson SC; Turney EA
    Arch Dermatol; 1992 Nov; 128(11):1467-73. PubMed ID: 1444500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical minoxidil solution (1% and 5%) in the treatment of alopecia areata.
    Fiedler-Weiss VC
    J Am Acad Dermatol; 1987 Mar; 16(3 Pt 2):745-8. PubMed ID: 3549811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3 percent topical minoxidil compared with placebo for the treatment of chronic severe alopecia areata.
    Fransway AF; Muller SA
    Cutis; 1988 Jun; 41(6):431-5. PubMed ID: 3292159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Efficacy of Diphenylcyclopropenone in Alopecia Areata: Retrospective Data Analysis of 50 Patients.
    Chiang KS; Mesinkovska NA; Piliang MP; Bergfeld WF
    J Investig Dermatol Symp Proc; 2015 Nov; 17(2):50-5. PubMed ID: 26551948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized trial of diphenylcyclopropenone (DPCP) combined with anthralin versus DPCP alone for treating moderate to severe alopecia areata.
    Ghandi N; Daneshmand R; Hatami P; Abedini R; Nasimi M; Aryanian Z; Vance TM
    Int Immunopharmacol; 2021 Oct; 99():107971. PubMed ID: 34298402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of topical diphenylcyclopropenone for the treatment of extensive alopecia areata.
    Cotellessa C; Peris K; Caracciolo E; Mordenti C; Chimenti S
    J Am Acad Dermatol; 2001 Jan; 44(1):73-6. PubMed ID: 11148480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical minoxidil. A preliminary review of its pharmacodynamic properties and therapeutic efficacy in alopecia areata and alopecia androgenetica.
    Clissold SP; Heel RC
    Drugs; 1987 Feb; 33(2):107-22. PubMed ID: 3552591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of anthralin in combination with diphenylcyclopropenone in the treatment of alopecia areata: a retrospective case series.
    Nasimi M; Ghandi N; Abedini R; Mirshamsi A; Shakoei S; Seirafi H
    Arch Dermatol Res; 2019 Oct; 311(8):607-613. PubMed ID: 31165933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical minoxidil dose-response effect in alopecia areata.
    Fiedler-Weiss VC; West DP; Buys CM; Rumsfield JA
    Arch Dermatol; 1986 Feb; 122(2):180-2. PubMed ID: 3947124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical immunotherapy with diphenylcyclopropenone in the treatment of chronic extensive alopecia areata.
    Sotiriadis D; Patsatsi A; Lazaridou E; Kastanis A; Vakirlis E; Chrysomallis F
    Clin Exp Dermatol; 2007 Jan; 32(1):48-51. PubMed ID: 17004987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double-blind, placebo-controlled evaluation of topical minoxidil in extensive alopecia areata.
    Price VH
    J Am Acad Dermatol; 1987 Mar; 16(3 Pt 2):730-6. PubMed ID: 3549809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical minoxidil for hair regrowth.
    Vanderveen EE; Ellis CN; Kang S; Case P; Headington JT; Voorhees JJ; Swanson NA
    J Am Acad Dermatol; 1984 Sep; 11(3):416-21. PubMed ID: 6384289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men.
    Olsen EA; Dunlap FE; Funicella T; Koperski JA; Swinehart JM; Tschen EH; Trancik RJ
    J Am Acad Dermatol; 2002 Sep; 47(3):377-85. PubMed ID: 12196747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of chronic extensive alopecia areata by diphenylcyclopropenone alone versus in combination with anthralin.
    Ibrahim SA; Esawy AM; Abdelshafy AS
    Dermatol Ther; 2019 Sep; 32(5):e13010. PubMed ID: 31237076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.